2-(5-oxo-2,3,4,5-tetrahydro-1-benzoxepin-7-yl)ethyl 4-methylbenzenesulfonate | 1176327-45-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噁庚英
• 英文名称: 2-(5-oxo-2,3,4,5-tetrahydro-1-benzoxepin-7-yl)ethyl 4-methylbenzenesulfonate
• 英文别名: 2-(5-oxo-3,4-dihydro-2H-1-benzoxepin-7-yl)ethyl 4-methylbenzenesulfonate
• CAS: 1176327-45-9
• 化学式: C₁₉H₂₀O₅S
• 分子量: 360.431
• InChiKey: VPBBDKFNUDANDC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  25
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  78
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-(5-oxo-2,3,4,5-tetrahydro-1-benzoxepin-7-yl)ethyl 4-methylbenzenesulfonate 、 4-[4-bromo-3-(2-methoxyethoxy)benzyl]piperidine hydrochloride 在 potassium carbonate 作用下， 以 乙腈 为溶剂， 反应 5.0h， 以99%的产率得到7-(2-{4-[4-bromo-3-(2-methoxyethoxy)benzyl]piperidin-1-yl}ethyl)-3,4-dihydro-1-benzoxepin-5(2H)-one
  参考文献：
  名称：

  Discovery of DSP-1053, a novel benzylpiperidine derivative with potent serotonin transporter inhibitory activity and partial 5-HT1A receptor agonistic activity

  摘要：

  We have previously shown that SMP-304, a serotonin uptake inhibitor with weak 5-HT1A partial agonistic activity, may act under high serotonin levels as a 5-HT1A antagonist that improves the onset of paroxetine in the rat swimming test. However, SMP-304 is mostly metabolized by CYP2D6, indicating limited efficacy among individuals and increased side effects. To reduce CYP2D6 metabolic contribution and enhance SERT/5-HT1A binding affinity, we carried out a series of substitutions at the bromine atom in the left part of the benzene ring of SMP-304 and replaced the right part of SMP-304 with a chroman4-one. This optimization work led to the identification of the antidepressant candidate DSP-1053 as a potent SERT inhibitor with partial 5-HT1A receptor agonistic activity. DSP-1053 showed low CYP2D6 metabolic contribution and a robust increase in serotonin levels in the rat frontal cortex. (c) 2018 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2018.02.008
• 作为产物：
  描述：

  4-[4-(carboxymethyl)phenoxy]butanoic acid 在 manganese(IV) oxide 、 lithium aluminium tetrahydride 、 三甲胺盐酸盐 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 24.5h， 生成 2-(5-oxo-2,3,4,5-tetrahydro-1-benzoxepin-7-yl)ethyl 4-methylbenzenesulfonate
  参考文献：
  名称：

  Discovery of DSP-1053, a novel benzylpiperidine derivative with potent serotonin transporter inhibitory activity and partial 5-HT1A receptor agonistic activity

  摘要：

  We have previously shown that SMP-304, a serotonin uptake inhibitor with weak 5-HT1A partial agonistic activity, may act under high serotonin levels as a 5-HT1A antagonist that improves the onset of paroxetine in the rat swimming test. However, SMP-304 is mostly metabolized by CYP2D6, indicating limited efficacy among individuals and increased side effects. To reduce CYP2D6 metabolic contribution and enhance SERT/5-HT1A binding affinity, we carried out a series of substitutions at the bromine atom in the left part of the benzene ring of SMP-304 and replaced the right part of SMP-304 with a chroman4-one. This optimization work led to the identification of the antidepressant candidate DSP-1053 as a potent SERT inhibitor with partial 5-HT1A receptor agonistic activity. DSP-1053 showed low CYP2D6 metabolic contribution and a robust increase in serotonin levels in the rat frontal cortex. (c) 2018 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2018.02.008

文献信息

• BENZYLPIPERIZINE COMPOUND
  申请人：Toyoda Tomohiro

  公开号：US20100113792A1

  公开（公告）日：2010-05-06

  Disclosed is a benzylpiperizine compound represented by formula (1) or a pharmaceutically acceptable salt thereof, which is useful as a medicinal agent such as an antidepressant agent. (In the formula (1), R 1 represents a hydrogen atom or a methyl group; R 2 is a group bound in a p- or m-position relative to a methylene group and represents a chlorine atom bound in a p-position, a bromine atom bound in a p-position, a methyl group bound in a p-position, a chlorine atom bound in a m-position or a bromine atom bound to in a m-position; X represents a methylene or an oxygen atom; and n represents an integer of 1 to 3.)

  揭示了一种由化学式（1）表示的苄基哌嗪化合物或其药学上可接受的盐，该化合物可用作药用剂，如抗抑郁剂。（在化学式（1）中，R1代表氢原子或甲基基团；R2是与亚甲基基团相对的p-或m-位置上结合的基团，代表结合在p-位置的氯原子、结合在p-位置的溴原子、结合在p-位置的甲基基团、结合在m-位置的氯原子或结合在m-位置的溴原子；X代表亚甲基或氧原子；n代表1到3的整数。）
• US8063223B2
  申请人：——

  公开号：US8063223B2

  公开（公告）日：2011-11-22
• US8232405B2
  申请人：——

  公开号：US8232405B2

  公开（公告）日：2012-07-31
• US8557998B2
  申请人：——

  公开号：US8557998B2

  公开（公告）日：2013-10-15
• [EN] BENZYLPIPERIZINE COMPOUND<br/>[FR] COMPOSÉ DE BENZYLPIPÉRIZINE
  申请人：DAINIPPON SUMITOMO PHARMA CO

  公开号：WO2009099087A1

  公开（公告）日：2009-08-13

  式（１）： ［式中、Ｒ1は、水素原子またはメチル基を表し、Ｒ2は、メチレン基に対してｐ位またはｍ位に結合した基であって、ｐ位に結合した塩素原子、ｐ位に結合した臭素原子、ｐ位に結合したメチル基、ｍ位に結合した塩素原子またはｍ位に結合した臭素原子を表し、Ｘは、メチレンまたは酸素原子を表し、ｎは、１～３の整数を表す。］ で表されるベンジルピペリジン化合物、またはその薬学上許容される塩は、抗うつ薬などの医薬として有用である。